Research Summary
Dr. Peter Stock is a transplant surgeon who specializes in kidney, liver and pancreas transplants. He is co-director of the Pancreatic Islet Cell Transplantation Program.
In his research, Stock studies body mechanisms that lead to transplant rejection when the donor and recipient are not genetically identical. He also studies chimerism (a therapy to prevent transplant rejection that uses the donor's bone marrow cells) and pancreatic islet cell transplantation (a procedure that can allow people with type 1 diabetes to discontinue insulin therapy).
Stock received his medical training at the University of Minnesota, completing a surgical residency before coming to UCSF for a transplant fellowship. He joined the UCSF faculty in 1992.
Stock is an active teacher and supervises surgical residents and fellows. He is a member of numerous professional and honorary societies.
Research Funding
August 1, 2016 - July 31, 2026 - Filling a Void of Research (FAVOR) Training for Transplant Surgeons , Principal Investigator . Sponsor: NIH, Sponsor Award ID: T32AI125222
August 19, 2015 - July 31, 2022 - Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients , Principal Investigator . Sponsor: NIH, Sponsor Award ID: U01AI118594
September 1, 2002 - March 31, 2021 - Diabetes Research Center , Co-Investigator . Sponsor: NIH, Sponsor Award ID: P30DK063720
January 15, 2015 - December 31, 2019 - Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant , Principal Investigator . Sponsor: NIH, Sponsor Award ID: U01AI115714
Education
Post-Doc Fellow/Scholar, 1991 - Medicine, University of California, San Francisco
M.D., 1982 - School of Medicine, University of Illinois
Residency, - , University of California, San Francisco